Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells

European Journal of Pharmacology
Francesca BellucciC A Maggi

Abstract

In the present study, we have investigated, by binding and functional experiments, the pharmacological profile of a new human tachykinin NK(2) receptor splice variant named beta isoform. Neurokinin A, nepadutant, SR48968 [(S)-N-methyl-N[4-(4-acetylamino-4-phenyl piperidino)-2-(3,4-dichlorophenyl) butyl]benzamide] and substance P have been tested for binding on the receptor expressed in whole CHO transfected cells. Only SR48968 binds, but with an affinity about sixfold lower in respect to the alpha isoform. Moreover, neurokinin A was unable to inhibit the [(3)H]SR48968 binding to the beta isoform up to microM concentrations. In cells expressing the human tachykinin NK(2) receptor beta isoform, contrary to those expressing the alpha isoform, natural or selective tachykinin receptor agonists (1 microM) were unable to produce a significant activation of inositol phosphate (IP) production or increase of intracellular calcium concentration [Ca(2+)](i). The recently discovered tachykinins, endokinins C and D, did not activate IP production or [Ca(2+)](i) increase in cells expressing the alpha or beta isoform of the human tachykinin NK(2) receptor. The present data indicate that the human tachykinin NK(2) receptor beta isoform is poorl...Continue Reading

References

Dec 1, 1979·Naunyn-Schmiedeberg's Archives of Pharmacology·F Lembeck, P Holzer
Mar 15, 1992·European Journal of Biochemistry·K TakahashiS Nakanishi
Sep 30, 1991·Biochemical and Biophysical Research Communications·Y TakedaJ E Krause
Sep 30, 1986·Biochemical and Biophysical Research Communications·Y KawaguchiS Nakanishi
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J E KrauseA D Hershey
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H KotaniS Nakanishi
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·G Urlaub, L A Chasin
Jul 29, 1994·Biochemical and Biophysical Research Communications·I Khan, S M Collins
Mar 31, 1993·Biochemical and Biophysical Research Communications·X Emonds-AltJ C Breliere
Apr 1, 1993·Physiological Reviews·M Otsuka, K Yoshioka
Jun 1, 1994·The Biochemical Journal·S Rose-John, P C Heinrich
Jan 22, 1993·Regulatory Peptides·N P GerardC Gerard
Jul 24, 1998·Biochemical and Biophysical Research Communications·A R RenzettiC A Maggi
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·K LingG Pei
Nov 9, 2000·Clinical and Experimental Pharmacology & Physiology·E N PatakM E Story
Nov 8, 2001·European Journal of Pharmacology·R Patacchini, C A Maggi
Nov 10, 2001·Trends in Endocrinology and Metabolism : TEM·P S Dannies
May 31, 2002·Pharmacological Reviews·Cinzia SeveriniVittorio Erspamer
Mar 26, 2003·Brain Research. Molecular Brain Research·Sarah J BakerIan L Gibbins
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Nigel M PagePhilip J Lowry
May 30, 2003·Biology of Reproduction·C Oscar PintadoM Luz Candenas
Jun 5, 2003·Expert Opinion on Therapeutic Targets·Alessandro Lecci, Carlo Alberto Maggi
Jun 6, 2003·British Journal of Pharmacology·Eva PatakFrancisco M Pinto
Jan 16, 2004·Trends in Pharmacological Sciences·Riccardo PatacchiniCarlo Alberto Maggi

❮ Previous
Next ❯

Citations

Jun 1, 2005·European Journal of Pharmacology·Stefania MeiniCarlo Alberto Maggi
Jul 25, 2009·Cellular and Molecular Life Sciences : CMLS·Danijela Markovic, R A John Challiss
Jul 8, 2008·Biochemical Pharmacology·Ingela AhlstedtErik Lindström
Dec 14, 2004·Life Sciences·Luz CandenasJocelyn N Pennefather
Feb 9, 2016·European Journal of Pharmacology·Ke ZhangPaul A Drew
Apr 18, 2006·Autonomic Neuroscience : Basic & Clinical·Alessandro LecciCarlo Alberto Maggi
Jun 20, 2015·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·M CorsettiJ Tack
Oct 7, 2008·European Journal of Pharmacology·Nadia JaafariJean Imbert

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Nigel M PagePhilip J Lowry
Cellular and Molecular Life Sciences : CMLS
Nigel M Page
Brain Research. Molecular Brain Research
Sarah J BakerIan L Gibbins
© 2021 Meta ULC. All rights reserved